Day One Biopharmaceuticals Stock Price Prediction
| DAWN Stock | USD 12.79 0.33 2.65% |
Oversold Vs Overbought
46
Oversold | Overbought |
EPS Estimate Next Quarter (0.62) | EPS Estimate Current Year (0.81) | EPS Estimate Next Year (1.12) | Wall Street Target Price 36.4444 | EPS Estimate Current Quarter (0.41) |
Using Day One hype-based prediction, you can estimate the value of Day One Biopharmaceuticals from the perspective of Day One response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Day One to buy its stock at a price that has no basis in reality. In that case, they are not buying Day because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Day One after-hype prediction price | USD 12.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Day |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Day One's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Day One After-Hype Price Prediction Density Analysis
As far as predicting the price of Day One at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Day One or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Day One, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Day One Estimiated After-Hype Price Volatility
In the context of predicting Day One's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Day One's historical news coverage. Day One's after-hype downside and upside margins for the prediction period are 10.60 and 15.10, respectively. We have considered Day One's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Day One is not too volatile at this time. Analysis and calculation of next after-hype price of Day One Biopharmaceu is based on 3 months time horizon.
Day One Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Day One is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Day One backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Day One, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 2.26 | 0.08 | 0.02 | 10 Events / Month | 6 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
12.79 | 12.85 | 0.55 |
|
Day One Hype Timeline
Day One Biopharmaceu is currently traded for 12.79. The entity has historical hype elasticity of -0.08, and average elasticity to hype of competition of -0.02. Day is anticipated to increase in value after the next headline, with the price projected to jump to 12.85 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.55%, whereas the daily expected return is currently at -0.14%. The volatility of related hype on Day One is about 1458.06%, with the expected price after the next announcement by competition of 12.77. Net Loss for the year was (188.92 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Day One Basic Forecasting Models to cross-verify your projections.Day One Related Hype Analysis
Having access to credible news sources related to Day One's direct competition is more important than ever and may enhance your ability to predict Day One's future price movements. Getting to know how Day One's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Day One may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| XFOR | X4 Pharmaceuticals | (0.22) | 10 per month | 10.68 | 0.04 | 13.85 | (13.51) | 67.48 | |
| INZY | Inozyme Pharma | (0.07) | 8 per month | 0.00 | (0.24) | 5.84 | (7.92) | 16.32 | |
| ABOS | Acumen Pharmaceuticals | (0.52) | 7 per month | 0.00 | (0.1) | 6.70 | (6.78) | 28.07 | |
| MREO | Mereo BioPharma Group | (0.23) | 6 per month | 0.00 | (0.11) | 4.71 | (6.31) | 16.40 | |
| TERN | Terns Pharmaceuticals | (0.05) | 10 per month | 0.00 | (0.19) | 5.17 | (6.80) | 26.61 | |
| ELDN | Eledon Pharmaceuticals | (0.09) | 5 per month | 3.55 | 0.19 | 10.09 | (6.84) | 28.12 | |
| HOOK | Hookipa Pharma | (0.20) | 7 per month | 0.00 | (0.31) | 6.85 | (6.67) | 22.36 | |
| PDSB | PDS Biotechnology Corp | 0.14 | 9 per month | 0.00 | (0.17) | 8.37 | (8.65) | 31.83 |
Day One Additional Predictive Modules
Most predictive techniques to examine Day price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Day using various technical indicators. When you analyze Day charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Day One Predictive Indicators
The successful prediction of Day One stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Day One Biopharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Day One based on analysis of Day One hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Day One's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Day One's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 33.43 | 20.94 | 12.72 | 22.7 | Net Debt To EBITDA | 3.92 | 0.6 | 1.12 | 1.83 |
Story Coverage note for Day One
The number of cover stories for Day One depends on current market conditions and Day One's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Day One is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Day One's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Day One Short Properties
Day One's future price predictability will typically decrease when Day One's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Day One Biopharmaceuticals often depends not only on the future outlook of the potential Day One's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Day One's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 79.8 M | |
| Cash And Short Term Investments | 366.3 M |
Check out Day One Basic Forecasting Models to cross-verify your projections. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.97) | Revenue Per Share 1.144 | Return On Assets (0.25) | Return On Equity (0.18) |
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.